{
  "nct_id": "NCT15512971",
  "indication": "Non-Small Cell Lung Cancer",
  "phase": "Phase 3",
  "sample_size": 331,
  "duration_weeks": 41,
  "dropout_rate": 0.19,
  "blinding": "double-blind",
  "control_arm": "placebo",
  "primary_endpoints": [
    "Objective response rate"
  ],
  "secondary_endpoints": [
    "Progression-free survival"
  ],
  "outcome_summary": "Primary endpoint met with statistical significance (p<0.05)",
  "success": 1,
  "start_date": "2021-04-15",
  "completion_date": "2022-01-27"
}